Skip to search formSkip to main contentSkip to account menu

cisplatin/melphalan/teniposide

Known as: CDDP/L-PAM/VM-26, VMP 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
PURPOSE This final analysis of the phase III VISTA trial (Velcade As Initial Standard Therapy in Multiple Myeloma: Assessment… 
Highly Cited
2012
Highly Cited
2012
The photovoltaic (PV) model is used in simulation studies to validate system design such as the maximum power point tracking… 
Highly Cited
2010
Highly Cited
2010
PURPOSE The purpose of this study was to confirm overall survival (OS) and other clinical benefits with bortezomib, melphalan… 
Highly Cited
2010
Highly Cited
2010
PURPOSE The combination of bortezomib-melphalan-prednisone (VMP) is a new standard of care for newly diagnosed multiple myeloma… 
Highly Cited
2006
Highly Cited
2006
Standard first-line treatment for elderly multiple myeloma (MM) patients ineligible for stem cell transplantation is melphalan… 
Highly Cited
2004
Highly Cited
1998
Highly Cited
1998
PURPOSE We report the results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC… 
Highly Cited
1996
Highly Cited
1996
A teal (Anas crecca) and a thrush nightingale (Luscinia luscinia) were trained to fly in the Lund wind tunnel for periods of up…